UCB's Global Corporate Website

Welcome to UCB in the United States

Newsroom

Find U.S. news and updates from UCB, a global biopharmaceutical company focused on creating value for people living with severe diseases, such as epilepsy, Parkinson’s disease, psoriasis, osteoporosis, myasthenia gravis, rheumatoid arthritis, psoriatic arthritis, non-radiographic axial spondyloarthritis, and more.

Spotlight Story

No results

UCB U.S. News

Nov 27, 2023

UCB's Commitment to Diversity, Equity, and Inclusion: Partnering at AES for a Better Future

Nov 17, 2023

Employee Spotlight: Stephen Mayclin’s Impact as a Working for Cures Champion and R&D Advocate

Nov 14, 2023

UCB Announces U.S. Availability of BIMZELX® for the Treatment of Adults with Moderate-to-Severe…

Twitter Feed

For More Information

Speaker Requests

Connect with Us on Social

@UCBUSA Twitter

UCB USA YouTube